Objective To update evidence‐based recommendations for the treatment of patients with
ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). Methods We …

Over the past 5 years, advances in high-throughput techniques and studies involving large
cohorts of patients have led to considerable advances in the identification of novel genetic …

Ankylosing spondylitis (AS) was first identified in the late 17th century. 250 years later,
inflammatory spine disease was recognized to be one of the patterns of psoriatic arthritis …

Objective To provide evidence‐based recommendations for the treatment of patients with
ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). Methods A …

Objective To study the effect of tumor necrosis factor α (TNFα) inhibitors on progressive
spinal damage in patients with ankylosing spondylitis (AS). Methods All AS patients meeting …

Background: Ankylosing spondylitis (AS) is a chronic inflammatory arthritis affecting the
spine in young adults. It is associated with excess cardiovascular and cerebrovascular …

Ankylosing spondylitis (AS) is a common, highly heritable, inflammatory arthritis for which
HLA-B* 27 is the major genetic risk factor, although its role in the aetiology of AS remains …

Quality of life (QOL) of patients affected by various diseases is now recognized as an
important outcome variable. Consenting patients with rheumatoid arthritis (American …

Objective To use high‐density genotyping to investigate the genetic associations of acute
anterior uveitis (AAU) in patients with and those without ankylosing spondylitis (AS) …

Objectives Axial spondyloarthritis (axSpA) is a complex disease with diverse manifestations,
for which new treatment options are warranted. BE MOBILE 1 (non-radiographic (nr)-axSpA) …